229 related articles for article (PubMed ID: 36257713)
21. Levetiracetam monotherapy for elderly patients with epilepsy.
Alsaadi TM; Koopmans S; Apperson M; Farias S
Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184
[TBL] [Abstract][Full Text] [Related]
22. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
Kinirons P; McCarthy M; Doherty CP; Delanty N
Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
[TBL] [Abstract][Full Text] [Related]
23. Levetiracetam monotherapy--outcomes from an epilepsy clinic.
Stephen LJ; Kelly K; Parker P; Brodie MJ
Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583
[TBL] [Abstract][Full Text] [Related]
24. Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types.
Fang Y; Wu X; Xu L; Tang X; Wang J; Zhu G; Hong Z
J Clin Neurosci; 2014 Jan; 21(1):55-62. PubMed ID: 24231559
[TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
Rhee SJ; Shin JW; Lee S; Moon J; Kim TJ; Jung KY; Park KI; Lee ST; Jung KH; Yu KS; Jang IJ; Chu K; Lee SK
Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care - an overview.
D'Onofrio G; Riva A; Amadori E; Lattanzi S; Rose K; Verrotti A; Striano P
Expert Opin Drug Metab Toxicol; 2022 Sep; 18(9):575-585. PubMed ID: 36006892
[TBL] [Abstract][Full Text] [Related]
27. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy.
Reisinger TL; Newman M; Loring DW; Pennell PB; Meador KJ
Epilepsy Behav; 2013 Oct; 29(1):13-8. PubMed ID: 23911354
[TBL] [Abstract][Full Text] [Related]
28. Effects of levetiracetam on seizure frequency and neuropsychological impairments in children with refractory epilepsy with secondary bilateral synchrony.
Kanemura H; Sano F; Sugita K; Aihara M
Seizure; 2013 Jan; 22(1):43-7. PubMed ID: 23127775
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of levetiracetam in STXBP1 encephalopathy with different phenotypic and genetic spectra.
Wang QH; Cao JJ; Wang YY; Zhang MN; Liu LY; Wang J; Lu Q; He W; Shen YW; Chen HM; Luo XM; Chen Q; Zou LP
Seizure; 2022 Feb; 95():64-74. PubMed ID: 35007884
[TBL] [Abstract][Full Text] [Related]
30. Relationship between bone density and levetiracetam monotherapy in epilepsy patients.
Gözükızıl ST; Aydın Z; Yalçın AD
Clin Neurol Neurosurg; 2022 Jul; 218():107270. PubMed ID: 35623138
[TBL] [Abstract][Full Text] [Related]
31. Long-term levetiracetam treatment of epilepsy patients: clinical audit.
Kuba R; Novotná I; Brázdil M; Kocvarová J; Tyrliková I; Mastík J; Rektor I
Epilepsy Res; 2006 Dec; 72(2-3):111-9. PubMed ID: 16930945
[TBL] [Abstract][Full Text] [Related]
32. Levetiracetam monotherapy in children with epilepsy: Experience from a tertiary pediatric neurology center.
Yıldırım M; Bektaş Ö; Akıncı Göktaş Ö; Yüksel MF; Şahin S; Tıraş Teber S
Epilepsy Behav; 2021 Mar; 116():107745. PubMed ID: 33508749
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of levetiracetam concentrations in plasma and saliva samples by ultra-performance liquid chromatography-tandem mass spectrometry: Application to therapeutic drug monitoring for pregnant women with epilepsy.
Zhang M; Jin Y; Li W; He C; Di X; Duan Y; Chen L; Wang Z
Biomed Chromatogr; 2024 Feb; 38(2):e5777. PubMed ID: 37990827
[TBL] [Abstract][Full Text] [Related]
34. Levetiracetam-Induced Seizure Aggravation in Patients With Focal Cortical Dysplasia.
Cvetkovska E; Kuzmanovski I; Babunovska M; Boshkovski B; Aleksovska K; Trencevska GK
Clin Neuropharmacol; 2018; 41(6):218-221. PubMed ID: 30234559
[TBL] [Abstract][Full Text] [Related]
35. Assessment into the usage of levetiracetam in a canine epilepsy clinic.
Packer RM; Nye G; Porter SE; Volk HA
BMC Vet Res; 2015 Feb; 11():25. PubMed ID: 25889090
[TBL] [Abstract][Full Text] [Related]
36. Dosage, time, and polytherapy dependent effects of different levetiracetam regimens on cognitive function.
Perkins JD; Abdelmoneim MS; Wilkins SS; Kamran S; Mesraoua B; Melikyan G; Alrabi A; El-Bardissy A; Elalamy O; Al Hail HJ
Epilepsy Behav; 2023 Nov; 148():109453. PubMed ID: 37783028
[TBL] [Abstract][Full Text] [Related]
37. Correlation of levetiracetam concentration in peripheral blood mononuclear cells with clinical efficacy: A sensitive monitoring biomarker in patients with epilepsy.
Harby SA; Nassra RA; Mekky JF; Ali SM; Ismail CA
Seizure; 2020 May; 78():71-77. PubMed ID: 32213443
[TBL] [Abstract][Full Text] [Related]
38. First-line levetiracetam versus enzyme-inducing antiseizure medication in glioma patients with epilepsy.
van der Meer PB; Maschio M; Dirven L; Taphoorn MJB; Koekkoek JAF;
Epilepsia; 2023 Jan; 64(1):162-169. PubMed ID: 36380710
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy.
Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS
J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270
[TBL] [Abstract][Full Text] [Related]
40. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
Glien M; Brandt C; Potschka H; Löscher W
Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
